Ferric carboxymaltose is a novel intravenous iron preparation used as an effective parenteral iron supplement. It features a core-shell structure consisting of a polynuclear ferric oxyhydroxide (β-FeOOH) core surrounded by a carbohydrate shell (oxidized maltodextrin, also known as carboxymaltose), which stabilizes iron and controls its release, thereby preventing toxic oxidative stress caused by transiently high serum iron levels and saturation of transferrin and ferritin. With a high iron content (24–32% by weight; 47.5–52.5 mg/mL in solution), it allows rapid administration of 500–1500 mg of iron over 15 minutes, requires fewer doses, and demonstrates excellent iron-repletion efficacy, significantly improving patient compliance.